Karyn A Goodman, MD, MS
- PROFESSOR | Radiation Oncology
- PROFESSOR | Medicine, Hematology and Medical Oncology
Karyn Aalami Goodman, MD, MS, is Professor and Vice Chair for Research and Quality in the Department of Radiation Oncology at the Icahn School of Medicine at Mount Sinai, and Associate Director for Clinical Research at The Tisch Cancer Institute. She is also Co-director of the Center of Excellence for Pancreatic Cancer.
Dr. Goodman is responsible for developing the infrastructure and resources to support cancer clinical trials across the Mount Sinai Health System.
Before joining Mount Sinai in September 2019, Dr. Goodman was Associate Director of Clinical Research at the University of Colorado Cancer Center, where she had worked since 2015. Previously, Dr. Goodman was the head of Gastrointestinal Radiation Oncology at Memorial Sloan Kettering Cancer Center from 2007 to 2015. She began her academic medicine career as an Assistant Professor, Radiation Oncology, at Stanford University in 2004.
An internationally recognized expert on gastrointestinal cancers, Dr. Goodman has served with several organizations, including the American Society of Clinical Oncology, to establish national treatment guidelines and best practices. She serves as Co-chair for the National Cancer Institute Gastrointestinal Steering Committee. Dr. Goodman’s research focuses on improving outcomes and reducing toxicity in patients with gastrointestinal malignancies. With extensive experience as principal investigator on clinical trials, she is involved in development of therapeutic protocols combining radiation, chemotherapy, targeted agents, and immunotherapy.
Dr. Goodman earned her MD from Stanford University and MS from Harvard School of Public Health. She completed an internship in internal medicine at Stanford and residency training in radiation oncology at Memorial Sloan Kettering Cancer Center.
Dr. Goodman is on Twitter at @KarynAGoodman
- Adrenal Cortical Carcinoma
- Anal Cancer
- Colorectal Cancer
- Esophageal Cancer
- Gallbladder Cancer
- Gastrointestinal Cancers
- Hepatobiliary Cancer
- Pancreatic Cancer
- Radiation Oncology
- Radiation Oncology Second Opinion
- Radiation Therapy
- Stomach (Gastric) Cancer
BA, Stanford University
MD, Stanford University School of Medicine
MA, Harvard School of Public Health
Internship, Internal Medicine, Stanford Hospital
Residency, Radiation Oncology, Memorial Sloan Kettering Cancer Center
Treatment Outcomes and Toxicity Reduction
My research goal is to improve treatment outcomes and reduce toxicity in patients with gastrointestinal malignancies by: (1) introducing and analyzing the use of cutting-edge radiation oncology technology, eg intensity-modulated radiotherapy, image-guided radiotherapy, and stereotactic body radiotherapy; (2) developing therapeutic protocols combining radiation, chemotherapy, and targeted agents for gastrointestinal cancer; and (3) investigating late effects of radiotherapy, including impact on quality of life.